Polar Capital Holdings’s Acceleron Pharma XLRN Stock Holding History

Polar Capital Holdings’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-390,488	Closed	-$67.2K	–	475
2021 Q3	$67.2K	Sell	390,488 -56,692	-13%	-$7.42M	0.27%	90
2021 Q2	$56.1K	Buy	447,180 +11,141	+3%	+$1.41M	0.24%	94
2021 Q1	$59.1M	Buy	436,039 +25,624	+6%	+$3.31M	0.37%	79
2020 Q4	$52.5M	Buy	+410,415	New	+$48.1M	0.32%	93

Polar Capital Holdings's XLRN Position: Q4 2021 in Review

Polar Capital Holdings sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 390,488 shares — an estimated $67.2K sold.

Polar Capital Holdings first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $59.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Polar Capital Holdings reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Polar Capital Holdings sold 390,488 Acceleron Pharma shares in Q4 2021, an estimated $67.2K.
Polar Capital Holdings first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Polar Capital Holdings's Acceleron Pharma position peaked at $59.1M in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Polar Capital Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.